Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04895722
Brief Title: Evaluation of Pembrolizumab (MK-3475) or Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008)

First Submitted : May 18, 2021
First Submitted that Met QC Criteria : May 18, 2021
First Posted : May 20, 2021

Last Update Submitted that Met QC Criteria : October 12, 2021
Last Update Posted : October 13, 2021